YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Bio-Rad Picks Up GnuBIO, Droplet-Based Sequencing


April 11, 2014 | Bio-Rad has acquired GnuBIO, a next-generation droplet-based DNA sequencing technology. The acquisition will establish a Bio-Rad research and development site in Cambridge, Mass. GnuBIO's DNA sequencing solution integrates the entire sample preparation workflow on a chip, from sample capture, PCR, and sequencing, to informatics, the company says. The goal is a simple, “Sample In, Answer Out” workflow to deliver results in hours. GnuBIO presented their technology at last October's Consumer Genetics Conference. Financial details were not disclosed. In October 2012, GnuBIO secured $10 million in funding, and the company co-founder spoke to Bio-IT World about the technology. Bio-Rad and GnuBIO Press Release
View Next Related Story
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.